Allogeneic GM-CSF Vaccine and Lenalidomide in Treating Myeloma Patients With Near Complete Remission
Clinical trial NCT01349569 · COMPLETED
Trial details
- NCT number
- NCT01349569
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-01-01
- Primary completion
- 2016-10-01
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.